Log in to your IBTimes Account

close
ID
Password

StemCells to issue up to $100M of securities



By AP
25 June 2008 @ 08:33 am EST

PALO ALTO, Calif. - Biotech company StemCells Inc. said Wednesday it has filed a new shelf registration statement with the Securities and Exchange Commission to issue up to $100 million of debt and equity securities.

Related Topic

Get stories by e-mail on this topic.

E-mail:
Quotes
STEM 0.84 0.06

SYMBOL LOOKUP

A shelf registration allows a company to sell securities from time to time in one or more separate offerings.

This shelf registration replaces the company's current one, which was filed in October 2005 and expires in December. The expiring shelf registration is for the issuance of up to $100 million of common stock, $59 million of which remains available. Any remaining shares under the expiring shelf will be de-registered once the new shelf is declared effective by the SEC, StemCells said.

Proceeds from any offerings may be used for future acquisitions, working capital and other corporate purposes, the company said.

StemCells shares closed Tuesday at $1.23.

Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Click!
  • Rate this article:

Comments

Post Your Comment

You must be an IBTimes member to post a comment. Login | Register


advertisement
More Industries
The Bush administration will spend $250 billion this year to purchase stock in banks and take a number of other bold steps in an effort to combat a globa...
Base metals prices have bounced due to an anticipated recovery of financial markets sparked by efforts to recapitalise banks.
Rio Tinto's unit Energy Resources of Australia has reported a 1% fall in uranium output for the third quarter.

Advertisement
Corporate Website Design

Professional Website Design For Corporate - Get a Free Quote Today

advertisement
 
IBTimes.com Web
Partners
International Business Times© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives